Effects of Patient-Driven Lifestyle Modification Using Intermittently Scanned Continuous Glucose Monitoring in Patients With Type 2 Diabetes: Results From the Randomized Open-label PDF Study

被引:20
|
作者
Choe, Hun Jee [1 ,2 ]
Rhee, Eun-Jung [3 ]
Won, Jong Chul [4 ]
Park, Kyong Soo [1 ,2 ]
Lee, Won-Young [3 ]
Cho, Young Min [1 ,2 ]
机构
[1] Seoul Natl Univ, Dept Internal Med, Coll Med, Seoul, South Korea
[2] Seoul Natl Univ Hosp, Div Endocrinol & Metab, Dept Internal Med, Seoul, South Korea
[3] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Div Endocrinol & Metab, Dept Internal Med,Sch Med, Seoul, South Korea
[4] Inje Univ, Sanggye Paik Hosp, Div Endocrinol & Metab, Dept Internal Med, Seoul, South Korea
关键词
SENSING TECHNOLOGY; REAL-TIME; NUTRITION; RECOMMENDATIONS; MULTICENTER; MANAGEMENT; ADULTS; CARE;
D O I
10.2337/dc22-0764
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE To investigate the effects of patient-driven lifestyle modification using intermittently scanned continuous glucose monitoring (isCGM) in patients with type 2 diabetes (T2D). RESEARCH DESIGN AND METHODS We conducted a 12-week, open-label, randomized controlled trial. A total of 126 participants were 1:1 randomized to either the intervention group (structured education + isCGM) or the control group (standard care with blood glucose monitoring). The Self-Evaluation Of Unhealthy foods by Looking at postprandial glucose (SEOUL) algorithm was developed and applied to aid structured education in guiding patients to follow healthy eating behavior depending on the postprandial glycemic response. The primary end point was the change in HbA(1c) level from baseline. RESULTS Implementation of the SEOUL algorithm with isCGM was associated with greater improvement in HbA(1c) than with standard care (risk-adjusted difference -0.50%, 95% CI -0.74 to -0.26, P < 0.001). Participants in the intervention group had a greater reduction in fasting blood glucose and body weight (-16.5 mg/dL, 95% CI -30.0 to -3.0, P = 0.017; -1.5 kg, 95% CI -2.7 to -0.3, P = 0.013, respectively). The score sum for the Korean version of the revised Summary of Diabetes Self-Care Activities Questionnaire increased in both groups but to a greater extent in the intervention group (mean difference 4.8, 95% CI 1.7-8.0, P = 0.003). No severe hyperglycemia or hypoglycemia was reported in either group of patients. CONCLUSIONS Patient-driven lifestyle modification primarily focused on eating behavior using isCGM effectively lowered HbA(1c) levels in patients with T2D.
引用
收藏
页码:2224 / 2230
页数:7
相关论文
共 50 条
  • [1] The importance of education for diabetes control in patients with type 1 diabetes using intermittently scanned continuous glucose monitoring
    Bem, R.
    Vavra, D.
    Hladikova, Z.
    Maskova, J.
    Havlova, V.
    Lachmanova, Z.
    Sochorova, K.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S337 - S337
  • [2] To evaluate the use and clinical effect of intermittently scanned continuous glucose monitoring in adults with type 1 diabetes: Results of a multicentre study
    Moreno-Fernandez, Jesus
    Sastre, Julia
    Pines, Pedro
    Calderon-Vicente, Dulce
    Gargallo, Javier
    Munoz-Rodriguez, Jose-Ramon
    ENDOCRINOLOGIA DIABETES Y NUTRICION, 2023, 70 (04): : 270 - 276
  • [3] Efficacy and Safety of Continuous Glucose Monitoring and Intermittently Scanned Continuous Glucose Monitoring in Patients With Type 2 Diabetes: A Systematic Review and Meta-analysis of Interventional Evidence
    Seidu, Samuel
    Kunutsor, Setor K.
    Ajjan, Ramzi A.
    Choudhary, Pratik
    DIABETES CARE, 2024, 47 (01) : 169 - 179
  • [4] Intermittently scanned continuous glucose monitoring in adults with type 1 diabetes: A subgroup analysis from the FLASH-UK study
    Leelarathna, Lalantha
    Sutton, Christopher J.
    Evans, Mark L.
    Neupane, Sankalpa
    Rayman, Gerry
    Lumley, Sarah
    Cranston, Iain
    Narendran, Parth
    Krishan, Ashma
    Taxiarchi, Vicky P.
    Barnard-Kelly, Katharine
    Elliott, Rachel A.
    Burns, Matthew
    Camm, Maisie
    Thabit, Hood
    Wilmot, Emma G.
    DIABETIC MEDICINE, 2024, 41 (03)
  • [5] Effects of intermittently scanned continuous glucose monitoring in adult type 1 diabetes patients with suboptimal glycaemic control: A multi-centre randomized controlled trial
    Yan, Jinhua
    Zhou, Yongwen
    Zheng, Xueying
    Zheng, Mao
    Lu, Jing
    Luo, Sihui
    Yang, Daizhi
    Deng, Hongrong
    Xu, Wen
    Bi, Yan
    Bao, Wei
    Weng, Jianping
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2023, 39 (04)
  • [6] Status of glycemic excursions and hypoglycemia in patients with type 1 diabetes 2 months after first initiation of intermittently scanned continuous glucose monitoring: a pilot study
    Yuka Suganuma
    Hiroshi Takahashi
    Rimei Nishimura
    Diabetology International, 2022, 13 : 672 - 678
  • [7] Status of glycemic excursions and hypoglycemia in patients with type 1 diabetes 2 months after first initiation of intermittently scanned continuous glucose monitoring: a pilot study
    Suganuma, Yuka
    Takahashi, Hiroshi
    Nishimura, Rimei
    DIABETOLOGY INTERNATIONAL, 2022, 13 (04) : 672 - 678
  • [8] Comparison of glycaemic metrics from simultaneous use of intermittently scanned and real-time continuous glucose monitoring in patients with type 1 diabetes
    Siolos, A.
    Christou, M.
    Katsarou, D.
    Christou, P.
    Zessides, C.
    Georga, E.
    Fotiadis, D.
    Tigas, S.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S411 - S411
  • [9] Lifestyle modification program, LIFE is LIGHT, in patients with type 2 diabetes mellitus and obesity: Results from a 48-week, multicenter, non-randomized, parallel-group, open-label study
    Galstyan, Gagik R.
    Valeeva, Farida V.
    Motkova, Svetlana I.
    Surkova, Elena V.
    Savelyeva, Larisa V.
    Rudina, Larisa M.
    Ramanathan, Krishnan
    Sokareva, Ekaterina
    Bondareva, Kristina
    Shestakova, Marina V.
    OBESITY SCIENCE & PRACTICE, 2021, 7 (04): : 368 - 378
  • [10] Multicenter Randomized Trial of Intermittently Scanned Continuous Glucose Monitoring Versus Self-Monitoring of Blood Glucose in Individuals With Type 2 Diabetes and Recent-Onset Acute Myocardial Infarction: Results of the LIBERATES Trial
    Ajjan, Ramzi A.
    Heller, Simon R.
    Everett, Colin C.
    Vargas-Palacios, Armando
    Higham, Ruchi
    Sharples, Linda
    Gorog, Diana A.
    Rogers, Alice
    Reynolds, Catherine
    Fernandez, Catherine
    Rodrigues, Pedro
    Sathyapalan, Thozhukat
    Storey, Robert F.
    Stocken, Deborah D.
    DIABETES CARE, 2023, 46 (02) : 441 - 449